This webinar covered
The rate at which the bispecific and immune checkpoint modulator landscapes are expanding is both promising and not without challenges; having access to this accurate and comprehensive information is paramount to informed decision-making.
To conclude our landscape review series, and to explore the array of data available across the bispecific and checkpoint landscapes, our research experts explored the drug and trial report data across both modalities and provided further exclusive insights. Key aspects explored included:
- A mid-year review of the drug landscape, discussing the 2000+ and 1700+ drugs respectively documented on Beacon
- An exploration of the current trial landscape, including all newly identified studies within H1 2023
- Insights into the effect of emerging trends and what we can expect in the future
Hosted by
Webinar Leaders
House Speaker
House Speaker
Speak with our team about Beacon Bispecific and Beacon Checkpoint
What is Beacon Bispecific?
Beacon Bispecific is manually curated by sector-specific scientists and includes clinical trial and drug records for preclinical, active, approved, and discontinued antibody-based drugs that are designed to bind to two or more target antigens. We also cover:
- Whole Antibodies
- Antibody Fragments
- Augmented Antibodies
- Bispecific Fusion Proteins
What is Beacon Checkpoint?
Beacon Checkpoint is a sector-specific curated database that includes trial and drug records for preclinical, active, approved, and discontinued:
- Immune Checkpoint Modulator Combinations
- Immune Checkpoint Modulators Monotherapies
- Across over 27 different checkpoint targets
How Beacon Bispecific and Beacon Checkpoint Works
Search the Bispecific clinical trial and drug landscape by multiple targets, scaffold and over 80 different bispecific formats instantaneously, or extract the data points you need to conduct more complex analyses.
Our intelligent Checkpoint search function instantly sweeps the clinical trial and drug landscape using 20 search criteria including therapeutic class, target, disease indication, developer, drug status and more. Search for combinations in trials or individual arms to avoid false positives.
Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the bispecific space.
How we target the data
We house all publicly available sources of data updated within 24 – 48 hours of publication proactively. Our sources cover (but are not limited to):
- Clinical trials registries
- Scientific journals and publications
- Company reports and presentations
- Press releases
- Conference reports and abstracts
- Government and regulatory organizations
- Newspapers and other media
- Patents
What is Beacon?
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
